CINXE.COM
Technology Meets Biology in Canada
<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <title> Technology Meets Biology in Canada </title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="canonical" href="https://www.biopharmatrend.com/post/607-technology-meets-biology-in-canada/" /> <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-YK7FCK71TD"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-YK7FCK71TD'); </script> <meta name="description" content="" /> <meta name="keywords" content="" /> <!-- Twitter Card data --> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:title" content="Technology Meets Biology in Canada"> <meta name="twitter:description" content=""> <meta name="twitter:image" content="https://www.biopharmatrend.com/files/blog/social/blog/post-cover-607_MnqU2BS.jpg"> <!-- Open Graph data --> <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.biopharmatrend.com/post/607-technology-meets-biology-in-canada/" /> <meta property="og:title" content="Technology Meets Biology in Canada" /> <meta property="og:description" content="" /> <meta property="article:published_time" content="2022-10-11T20:24:13+00:00"> <meta property="article:modified_time" content="2022-10-11T20:24:13+00:00"> <meta name="author" content="Andrii Buvailo, Natalia Honchar"> <meta property="og:image" content="https://www.biopharmatrend.com/files/blog/social/blog/post-cover-607_MnqU2BS.jpg"> <script type="application/ld+json">{ "@context": "https://schema.org", "@type": "Article", "headline": "Technology Meets Biology in Canada", "datePublished": "2022-10-11T20:24:13+00:00", "dateModified": "2022-10-11T20:24:13+00:00", "description": "Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.", "image": "https://www.biopharmatrend.com/files/blog/social/blog/post-cover-607_MnqU2BS.jpg", "url": "https://www.biopharmatrend.com/post/607-technology-meets-biology-in-canada/", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.biopharmatrend.com/post/607-technology-meets-biology-in-canada/" }, "publisher": { "@type": "Organization", "name": "BiopharmaTrend", "url": "https://www.biopharmatrend.com", "logo": { "@type": "ImageObject", "url": "https://www.biopharmatrend.com/static/img/bpt_logo.png" } }, "author": [ { "@type": "Person", "name": "Andrii Buvailo, PhD", "url": "https://www.biopharmatrend.com/contributor/9/" }, { "@type": "Person", "name": "Natalia Honchar", "url": "https://www.biopharmatrend.com/contributor/1092/" } ] }</script> <style type="text/css"> .ap-chart-load svg { width: 100%; } .post-meta .author-linkein-icon { width: 1em; vertical-align: baseline; } .text-miniblock { display: inline-block; box-shadow: 0 0 6px -1px forestgreen; background: white; padding: 0.5rem; } .post .text-miniblock a { color: black; } .post .text-miniblock a:hover, .post .text-miniblock a:active { color: #333; text-decoration: underline; } .text-miniblock-right { float: right; margin: 0 0 1rem 1rem; max-width: 14rem; } .subscribe-block { background-color: deepskyblue; color: white; margin-top: 1.5rem; margin-bottom: 2rem; padding-top: 1.5rem; padding-bottom: 1.5rem; width: calc(50% + 100vw); padding-left: calc(50vw - 50%); padding-right: 50vw; margin-left: calc(50% - 50vw); position: relative; } .subscribe-block > .subscribe-inner { background-image: url('/files/subscription-bg.png'); background-position: right bottom; background-size: auto 120%; background-repeat: no-repeat; } .mobile-only { display: none; } @media screen and (max-width: 34em) { .text-miniblock-right { float: none; margin: 1rem 0; max-width: 100%; } .subscribe-block > .subscribe-inner { background-image: unset; } .mobile-only { display: block; } } </style> <link rel="shortcut icon" href="/static/favicon.ab1145f4d518.ico" /> <link rel="stylesheet" type="text/css" href="/static/css/main.6dead4e2266d.css" /> </head> <body> <div id="main-preheader"> <div class="container block-preheader"> <div id="logo-top"> <a href="/"><b>BioPharmaTrend</b></a> <!-- <a href="/"><img src="/files/bpt_logo2.svg" alt="BioPharmaTrend" style="max-height: 1em;" /></a> --> </div> <div class="burger-container"> <div class="burger-button-container"> <button type="button" class="burger-button" onclick="document.documentElement.classList.toggle('blockfix');this.parentElement.parentElement.classList.toggle('active');"> <div class="burger-line burger-line-1"></div> <div class="burger-line burger-line-2"></div> <div class="burger-line burger-line-3"></div> </button> </div> <!-- Search block --> <div id="main-search-menu"> <div class="top-search"> <form action="/search/" class="top-search-form"> <button type="submit" class="btn btn-default"><i class="glyphicon glyphicon-search"></i></button> <input type="text" name="q" value="" size="10" class="form-control form-control-inline" required="" placeholder="e.g. 'quantum tech' or 'stem cell'"> <input type="hidden" name="section" value="insights"> </form> <span class="top-search-switcher button" onclick="this.parentElement.classList.toggle('active')"> <span class="glyphicon glyphicon-search"></span> <span class="glyphicon glyphicon-remove"></span> </span> </div> <span class="top-search-switcher button"> <span class="glyphicon glyphicon-search"></span> </span> </div> <!-- Main Menu block --> <nav id="main-menu"> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/news/"><b>Latest News</b></a> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">All Topics <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/topic/bioeconomy-society/">Bioeconomy & Society</a></li> <li><a class="top-menu-link" href="/topic/ai-digital/">AI & Digital</a></li> <li><a class="top-menu-link" href="/topic/startups/">Startups & Deals</a></li> <li><a class="top-menu-link" href="/topic/neurotech/">NeuroTech</a></li> <li><a class="top-menu-link" href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a class="top-menu-link" href="/topic/synbio/">Biotech</a></li> <li><a class="top-menu-link" href="/topic/tools-methods/">Tools & Methods</a></li> <li><a class="top-menu-link" href="/topic/healthtech/">HealthTech</a></li> <li><a class="top-menu-link" href="/topic/aging-research/">Aging & Longevity</a></li> <li><a class="top-menu-link" href="/topic/contract-research/">Contract Research</a></li> <div class="sub-menu-margin"></div> <!--<li><a class="top-menu-link" href="/ai-drug-discovery-pipeline/">Historical Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/section/latest/">Latest insights</a></li> <li><a class="top-menu-link" href="/premium-content/">Premium Content</a></li> <div class="sub-menu-margin" style="border-bottom: 1px solid limegreen;"></div> <li><a class="top-menu-link" href="/knowledge-center/">Knowledge Center</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/interviews/"><b>Interviews</b></a> </div> <!-- <div class="mobile-menu-item"> <b class="mobile-menu-item-title">Library</b> </div> --> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">Companies <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <!-- <li><a class="top-menu-link" href="/post/789-a-landscape-of-ai-discovered-molecules-and-target-novelty-analysis/">AI Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/m/marketplace/">Company Directory</a></li> <li><a class="top-menu-link" href="/section/interviews/">Interviews with Thought Leaders</a></li> <li><a class="top-menu-link" href="/section/case-studies/">Sponsored Case Studies</a></li> <li><a class="top-menu-link" href="/m/editor-tool/">Create Company Profile</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">More <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/about/">About Us</a></li> <li><a class="top-menu-link" href="/about/team/">Our Team</a></li> <li><a class="top-menu-link" href="/about/advisory-board/">Advisory Board</a></li> <li><a class="top-menu-link" href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a class="top-menu-link" href="/events/">Partner Events Calendar</a></li> <li><a class="top-menu-link" href="/advertising-media-kit/">Advertise with Us</a></li> <li><a class="top-menu-link" href="/contributor/">Write for Us</a></li> </ul> </div> </div> </nav> </div> <div id="main-user-actions"> <!-- Subscribe block --> <div class="mobile-menu-item"> <a href="/membership/" class="button-subscribe top-menu-link">Subscribe</a> </div> <!-- User menu --> <div class="mobile-menu-item last"> <a href="#" class="mobile-menu-item-title" rel="nofollow" title="Login/Join" onclick="document.getElementById('login-popup').classList.toggle('hidden')"> <span class="glyphicon glyphicon-log-in"></span> <span class="mobile-hide-m">Login/Join</span> </a> </div> </div> </div> </div> <div id="main-preheader-margin"></div> <div id="sencondary-menu-block"> <div class="container clearfix"> <nav> <ul class="text-center"> <li><a href="/topic/ai-digital/">AI & Digital</a></li> <li><a href="/topic/startups/">Startups & Deals</a></li> <li><a href="/topic/neurotech/">NeuroTech</a></li> <li><a href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a href="/topic/synbio/">Biotech</a></li> <li><a href="/topic/tools-methods/">Tools & Methods</a></li> </ul> </nav> </div> </div> <!-- <header id="main-header" class="brand-block"> <div class="container clearfix"> </div> </header> --> <div id="main-content" class="container"> <main id="content" class="col-lg-9 col-md-8 col-sm-12 col-xs-12"> <div class="mobile-only"> </div> <article id="post-607" class="post "> <header> <h1>Technology Meets Biology in Canada</h1> </header> <footer class="post-meta"> <div class="tooltip"> <span class="glyphicon glyphicon-pencil"></span> by <a href="/contributor/9/">Andrii Buvailo, PhD</a> <a href="https://www.linkedin.com/in/andriibuvailo/" rel="nofollow" target="_blank"> <img src="/static/img/linkedin_icon_50x50.71dcf83d1029.png" class="author-linkein-icon" /> </a> </span> , <a href="/contributor/1092/">Natalia Honchar</a> <a href="https://www.linkedin.com/in/natalia-honchar/" rel="nofollow" target="_blank"> <img src="/static/img/linkedin_icon_50x50.71dcf83d1029.png" class="author-linkein-icon" /> </a> <span class="tooltip-trigger" onclick="this.parentElement.classList.toggle('tooltip-show')"> Contributor <i class="glyphicon glyphicon-info-sign"></i> </span> <span style="white-space: nowrap;"> <span class="glyphicon glyphicon-folder-open"></span> Biopharma insight / Biopharma Insights </span> <div class="tooltip-text"> <div class="tooltip-close" onclick="this.parentElement.parentElement.classList.toggle('tooltip-show');"></div> <p><b>Disclaimer</b>: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. <br> Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.</p> </div> </div> <div> <span class="glyphicon glyphicon-calendar" title="Published on"></span> <time datetime="2022-10-11">Oct. 11, 2022</time> </em> </div> <div class="tags"> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a> </div> <div> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> | <a href="/post/607-technology-meets-biology-in-canada/pdf/" target="_blank" rel="nofollow"> <span style="vertical-align: text-top; color: deepskyblue; font-size: 1.5em;" class="glyphicon glyphicon-print"></span></a> </div> </footer> <section> <p><meta charset="utf-8" />Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.</p> <p><meta charset="utf-8" />The technological focus of the country’s economic strategy is reflected, for instance, in the local popularity of such organizations as the Canadian Institute for Advanced Research (CIFAR), which celebrates 40 years since its foundation in 2022. CIFAR is gaining the support of multiple individuals, organizations, and the governmental bodies of Canada -- in Alberta and Quebec. For example, in 2017, the government of Canada gave a lead to CIFAR in developing the $125M <a href="https://cifar.ca/ai/">Pan-Canadian AI Strategy</a>. According to their vision, by 2030, Canada could have one of the most robust national AI ecosystems worldwide.</p> <p dir="ltr">In our recent article <a href="https://www.biopharmatrend.com/post/98-toronto-ai-startups-aim-high-in-drug-discovery-space/">Toronto’s Blossoming AI-driven Drug Discovery Scene</a> we explored a vibrant AI community of Toronto with several notable artificial intelligence companies in drug discovery, including Cyclica, ProteinQure, Deep Genomics, Phenomic AI, and others. The city appears to be a leading hub in the region, fueled in part by the presence of the University of Toronto and its tech community. </p> <p dir="ltr">BenchSci is a Google-backed tech company redefining how e-commerce should work in the life sciences. At the beginning of 2022, BenchSci completed a Series C funding round with C$63 million led by Inovia Capital and TCV. BenchSci is expected to further expand its AI-powered software platform, tailored as a reagent and model systems selection algorithm. </p> <p dir="ltr">Founded in 2013, Cyclica is a Toronto-based neo-biotech focusing on proteome-wide AI-enabled computing. They developed two machine learning engines: MatchMaker and POEM, where the first one predicts the polypharmacology of small molecules. At the same time, POEM (Pareto Optimal Embedding Model) is a similarity-based property prediction model. In February 2022, Cyclica launched Perturba Therapeutics, a spin-out from the University of Toronto focused on AI-enabled oncology drug design.</p> <p dir="ltr">The development of cell and gene therapies also does not stand still in Canada. Contract development and manufacturing organization (CDMO) OmniaBio Inc., a subsidiary of the Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM), specializes in producing gene-modified cell therapies and viral vectors. According to the news of spring 2022, Ontario province would invest up to $40M to create a new manufacturing facility for OmniaBio at Hamilton’s McMaster Innovation Park. The money is raised through <a href="https://www.investontario.ca/">Invest Ontario</a>, the province’s investment attraction agency, taking part in the general project investment of over $580M.</p> <p dir="ltr">Additionally, in July 2022, a South Korea-based Medipost acquired an interest in OmniaBio, paying cash $30 million and investing an additional $60M, followed by the NGen’s contribution of $10.5 million in September 2022. </p> <p dir="ltr">Founded in Toronto, BlueRock Therapeutics focuses on cell therapies, having therapeutic candidates at the clinical trials stage. As an example, the cell therapy for Parkison's disease BRT-DA01 entered the open-label Phase 1 study in June 2022, marked with the completed enrollment in the study. Bayer acquired the company in 2019, and now it functions as Bayer’s subsidiary. </p> <p dir="ltr">It should be noted that Toronto is not the only place to be in tech-savvy biology research and entrepreneurship in Canada. For example, a notable company from British Columbia in the area of quantum computing is D-Wave, which is developing practical applications for real-world problems, including pharmaceutical research. In the exclusive interview with BiopharmaTrend: <a href="https://www.biopharmatrend.com/post/309-interview-how-d-wave-brings-quantum-computing-into-biology/">How D-Wave Brings Quantum Computing Into Biology</a>, Murray Thom, VP of Software and Cloud Services at D-Wave, gave many insights into how quantum computing works and how it is practically applied for drug development purposes. In February 2022, the company went public via SPAC route. Importantly, D-Wave was supported by several grants from the Canadian government for a total of around $50 million, along with other investors.</p> <p dir="ltr">Another notable Vancouver-based company, a clinical-stage biotech AbCellera, made headlines in 2020 when it closed the biggest-ever initial public offering by a Canadian biotechnology company raising US$555.5 million in gross proceeds, more than double the prior record for a Canadian biotech IPO, by Montreal’s Repare Therapeutics in June of the same year. AbCellera created an end-to-end antibody discovery platform enabled by advanced machine learning algorithms. </p> <p dir="ltr">In May 2020, AbCellera received $175.6 million from the government of Canada to discover solutions for COVID-19 and build a manufacturing facility for antibody drugs. </p> <p dir="ltr">The role of venture capital firms and business accelerators should not be undervalued in Canada’s life science community. For instance, Vancouver-based <a href="https://www.biopharmatrend.com/post/179-interview-building-canadas-life-sciences-community-and-thinking-global/">adMare BioInnovations</a> is a global life sciences venture which is enhancing the biotech ecosystem growth in Canada. In September 2022, they announced a new partnership with Genome Canada, aiming to support the commercialization of genomics solutions in healthcare. Notably, adMare is also not left aside without governmental support: in March 2022 Minister of Innovation, Science and Industry of Canada announced a $92 million investment in adMare Bio Innovations to help translate promising health research into commercialized therapies. With the innovation centers in Vancouver and Montreal, multiple stakeholders can get adMare’s scientific expertise, research infrastructure, and business development support.</p> <p dir="ltr">Overall, the COVID-19 pandemic influenced the landscape of the Canadian Life Science sector. In October 2022, the government announced C$11.1 million in funding for mRNA vaccine technology development at the University of British Columbia. The funding is sourced through the Pacific Economic Development Agency of Canada <a href="https://www.canada.ca/en/pacific-economic-development.html">(PacifiCan)</a> to enhance the delivery and efficacy of mRNA vaccines. One of the projects will receive C$3.5 million of PacifiCan support to improve vaccine uptake in the human body. The rest of the funding was secured for addressing the emerging COVID-19 variants, preventing their further spreading. </p> <blockquote> <p dir="ltr">"PacifiCan is committed to supporting British Columbia’s life sciences sector, and these projects at the University of British Columbia reflect that commitment. Establishing a home-grown pipeline for mRNA vaccine research will not only save lives but create jobs for British Columbians and position Canada as a global leader in biotechnology innovation,” commented the Minister of International Development Harjit S. Sajjan</p> </blockquote> <p dir="ltr">At the same time, in April 2022, it was announced that Montreal will become a host of a new Moderna vaccine production and research facility. It is expected to open in 2024 and give 200 to 300 new job places, as well as additional R&D capacities. The announcement was made at McGill University in Montreal, where Prime Minister Justin Trudeau also mentioned the potential of mRNA technology for not only COVID-19 but also Alzheimer’s and cancer treatment. </p> <p dir="ltr">The growing dynamics of the local life science industry are fueled by the favorable Canadian tech environment with early programs and funding provided by multiple research institutes and councils, as well as hundreds of government investment programs with private sector initiatives. Last but not least, the government also offers grant programs and start-up visas for overseas entrepreneurs who want to launch their companies in Canada, thereby stimulating professional immigration to Canada. </p> <div class="product-list"> <a href="/m/company/benchsci/" class="btn btn-bpt-white">BenchSci</a> <a href="/m/company/bluerock-therapeutics/" class="btn btn-bpt-white">BlueRock Therapeutics</a> <a href="/m/company/cyclica/" class="btn btn-bpt-white">Cyclica</a> <a href="/m/company/deep-genomics/" class="btn btn-bpt-white">Deep Genomics</a> <a href="/m/company/phenomic-ai/" class="btn btn-bpt-white">Phenomic AI</a> <a href="/m/company/proteinqure/" class="btn btn-bpt-white">ProteinQure</a> </div> <p> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a> </p> </section> </article> <div style="margin: 1em 0 2em; padding: 0.5em 0;"> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/607-technology-meets-biology-in-canada/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> </div> <div class="subscribe-block"> <div class="subscribe-inner"> <h3 style="line-height:1.5; font-weight: 900;"> <span style="font-weight: 900">Get Exclusive Insights Into Your Inbox</span> <br> <span style="font-weight: normal;">join 7000+ BPT insiders</span> </h3> <br> <div> <a style="font-size: 1.25em;width:17em; text-align: center; border-color: white; color: white; font-weight: 900" href="#" onclick="toggleMailingPopup(true)" class="btn">Subscribe</a> </div> </div> </div> <section id="comments"> </section> </main> <aside id="main-sidebar" class="col-lg-3 col-md-4 col-sm-12 col-xs-12"> <section class="well"> <h4>Latest Articles</h4> <ul> <li><a href="/post/1029-novartis-expands-radiopharmaceutical-portfolio-with-745m-deal-with-ratio-therapeutics/">Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics</a></li> <li><a href="/post/1024-immunai-and-teva-collaborate-to-advance-clinical-trials-in-oncology-and-immunology/">Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology</a></li> <li><a href="/post/1022-genesis-therapeutics-collaborates-with-nvidia-and-secures-additional-nventures-funding-to-accelerate-ai-driven-drug-discovery/">Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery</a></li> <li><a href="/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/">Schrödinger and Novartis Forge Partnership to Scale Computational Drug Discovery</a></li> <li><a href="/post/1016-tempus-ai-to-acquire-ambry-genetics-for-600-million/">Tempus AI to Acquire Ambry Genetics for $600 Million</a></li> <li><a href="/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/">UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report</a></li> </ul> </section> </aside> </div> <footer id="main-footer"><div class="container"> <div class="row"> <div class="col-12 col-sm-6 col-lg-3"> <h4 class="footer-logo"><span style="font-weight: 900">BiopharmaTrend</span>.com</h4> <div style="margin-bottom: 1.25em" class="footer-logo-slogan">Where Tech Meets Bio</div> <!-- <p> <a style="color: #fff;border-color: #fff;" href="#main-footer" onclick="toggleMailingPopup(true)" class="btn"><b>Newsletter</b></a> </p> <p> <a href="https://www.linkedin.com/company/18118496" rel="nofollow" target="_blank"><img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /></a> <a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"><img src="/static/img/sm-tw.f721ec7f127d.png" alt="tw" width="32" height="32" /></a> <a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"><img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /></a> <a href="/rss/" rel="nofollow" target="_blank"><img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /></a> </p> --> <div style="margin-bottom: 0.5em;"><a href="#main-footer" onclick="toggleMailingPopup(true)" style="color: lemonchiffon"> <img src="/static/img/sm-mail.a3210e82fe37.png" alt="mail" width="32" height="32" /> <b>Newsletter</b> </a></div> <div style="margin-bottom: 0.5em"><a href="https://www.linkedin.com/company/biopharmatrend-com/" rel="nofollow" target="_blank"> <img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /> LinkedIn </a></div> <div style="margin-bottom: 0.5em"><a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"> <img src="/static/img/sm-x.9f3327271e1a.png" alt="x" width="32" height="32" /> X </a></div> <div style="margin-bottom: 0.5em"><a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"> <img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /> Google News </a></div> <div><a href="/rss/" rel="nofollow" target="_blank"> <img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /> RSS Feed </a></div> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>About</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/about/">What we do</a></li> <li><a href="/editorial-calendar/">Editorial Calendar</a></li> <li><a href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a href="/terms-of-use/">Terms of Use</a></li> <li><a href="/privacy-policy/">Privacy Policy</a></li> <!--<li><a href="/cookies-policy/">Cookies Policy</a></li>--> <li><a href="/about/disclaimer/">Disclaimer</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>We Offer</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/premium-content/"><b style="color: lemonchiffon">Premium Content</b></a></li> <li><a href="/m/marketplace/">BioTech Scout</a></li> <li><a href="/our-products/">Reports</a></li> <li><a href="/section/interviews/">Interviews</a></li> <li><a href="/events/">Partner Events</a></li> <li><a href="/section/case-studies/">Case Studies</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>Opportunities</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/membership/">Membership</a></li> <li><a href="/advertising-media-kit/">Advertise</a></li> <li><a href="/m/editor-tool/">Submit Company</a></li> <li><a href="/contributor/">Write for Us</a></li> <li><a href="/guest-blog/guidelines/">Author Guidelines</a></li> <li><a href="/a/contact/">Contact Us</a></li> </ul> </nav> </div> </div> <hr> <div class="text-right">© BPT Analytics LTD 2024</div> </div></footer> <div id="bpt-consent"><div class="container"> <div class="row"> <div class="col-12 col-md-6 col-lg-8"> We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our <a href="/cookies-policy/">cookies policy</a>. </div> <div class="col-12 col-md-6 col-lg-4 text-right"> <button class="btn btn-primary btn-sm" type="button" onclick="changeConsent('analytics')" style="white-space:unset">Agree</button> </div> </div> </div></div> <div id="login-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div class="popup-content" style="width: 25em;"> <form method="post" class="api-form" action="/a/login/?next=/post/607-technology-meets-biology-in-canada/"></form> </div> </div> <div id="subscription-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div id="subscription-popup-iframe" class="popup-content" style="width: 25em;"> </div> </div> <div id="scroll-top-pixel-anchor"></div> <button id="go-top" onclick="window.scrollTo({top: 20, left: 0, behavior: 'smooth'})">^</button> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script> <script src="/static/js/main.df923d2272d3.js"></script> <script type="text/javascript"> if ( "IntersectionObserver" in window && "IntersectionObserverEntry" in window && "intersectionRatio" in window.IntersectionObserverEntry.prototype ) { let observer = new IntersectionObserver(entries => { if (entries[0].boundingClientRect.y < 0) { document.body.classList.add("scroll-top"); } else { document.body.classList.remove("scroll-top"); } }); observer.observe(document.getElementById("scroll-top-pixel-anchor")); } </script> <script src="/static/js/blog-ajax.eb8cbd906073.js"></script> <script> const comments_url = "/blog-api/comments/post-607"; post_comments_load(); </script> </body> </html>